Literature DB >> 25060360

Adverse drug reactions - examples of detection of rare events using databases.

Esther W Chan1, Kirin Q L Liu1, Celine S L Chui1, Chor-Wing Sing1, Lisa Y L Wong1, Ian C K Wong1.   

Abstract

It is recognised that randomised controlled trials are not feasible for capturing rare adverse events. There is an increasing trend towards observational research methodologies using large population-based health databases. These databases offer more scope for adequate sample sizes, allowing for comprehensive patient characterisation and assessment of the associated factors. While direct causality cannot be established and confounders cannot be ignored, databases present an opportunity to explore and quantify rare events. The use of databases for the detection of rare adverse events in the following conditions, sudden death associated with attention deficit hyperactivity disorder (ADHD) treatment, retinal detachment associated with the use of fluoroquinolones and toxic epidermal necrolysis associated with drug exposure, are discussed as examples. In general, rare adverse events tend to have immediate and important clinical implications and may be life-threatening. An understanding of the causative factors is therefore important, in addition to the research methodologies and database platforms that enable the undertaking of the research.
© 2014 The British Pharmacological Society.

Entities:  

Keywords:  adverse drug reactions; attention deficit hyperactivity disorder; database; retinal detachment; sudden death; toxic epidermal necrolysis (TEN)

Mesh:

Substances:

Year:  2015        PMID: 25060360      PMCID: PMC4594728          DOI: 10.1111/bcp.12474

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  32 in total

1.  Association between recent use of fluoroquinolones and rhegmatogenous retinal detachment: a population-based cohort study.

Authors:  Shu-Chen Kuo; Yung-Tai Chen; Yi-Tzu Lee; Nai-Wen Fan; Shih-Jen Chen; Szu-Yuan Li; Chia-Jen Liu; Te-Li Chen; Tzeng-Ji Chen; Chang-Phone Fung
Journal:  Clin Infect Dis       Date:  2013-10-28       Impact factor: 9.079

2.  Oral fluoroquinolones and the risk of retinal detachment.

Authors:  Mahyar Etminan; Farzin Forooghian; James M Brophy; Steven T Bird; David Maberley
Journal:  JAMA       Date:  2012-04-04       Impact factor: 56.272

3.  Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder.

Authors:  Mark Olfson; Cecilia Huang; Tobias Gerhard; Almut G Winterstein; Stephen Crystal; Paul D Allison; Steven C Marcus
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2011-12-20       Impact factor: 8.829

4.  Risk of retinal tear or detachment with oral fluoroquinolone use: a cohort study.

Authors:  Kian Eftekhari; Devon H Ghodasra; Kevin Haynes; Jinbo Chen; John H Kempen; Brian L VanderBeek
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-04-22       Impact factor: 2.890

5.  Oral fluoroquinolones and the incidence of rhegmatogenous retinal detachment and symptomatic retinal breaks: a population-based study.

Authors:  Kapil G Kapoor; David O Hodge; Jennifer L St Sauver; Andrew J Barkmeier
Journal:  Ophthalmology       Date:  2014-01-28       Impact factor: 12.079

6.  Association between oral fluoroquinolone use and retinal detachment.

Authors:  Björn Pasternak; Henrik Svanström; Mads Melbye; Anders Hviid
Journal:  JAMA       Date:  2013-11-27       Impact factor: 56.272

7.  Epidemiology of ophthalmologic disease associated with erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis in hospitalized children in the United States.

Authors:  Jacqueline F Moreau; Robert S Watson; Mary E Hartman; Walter T Linde-Zwirble; Laura K Ferris
Journal:  Pediatr Dermatol       Date:  2013-05-16       Impact factor: 1.588

8.  An investigation of the potential association between retinal detachment and oral fluoroquinolones: a self-controlled case series study.

Authors:  Celine S L Chui; Kenneth K C Man; Ching-Lan Cheng; Esther W Chan; Wallis C Y Lau; Vincent C C Cheng; David S H Wong; Yea-Huei Yang Kao; Ian C K Wong
Journal:  J Antimicrob Chemother       Date:  2014-05-15       Impact factor: 5.790

9.  Multi-indication carbamazepine and the risk of severe cutaneous adverse drug reactions in Korean elderly patients: a Korean health insurance data-based study.

Authors:  Ji Young Kim; Joongyub Lee; Young-Jin Ko; Ju-Young Shin; Sun-Young Jung; Nam-Kyong Choi; Byung-Joo Park
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

10.  Exposure to oral fluoroquinolones and the risk of retinal detachment: retrospective analyses of two large healthcare databases.

Authors:  Daniel Fife; Vivienne Zhu; Erica Voss; Grace Levy-Clarke; Patrick Ryan
Journal:  Drug Saf       Date:  2014-03       Impact factor: 5.606

View more
  10 in total

1.  Adverse drug reactions.

Authors:  Michael Rieder; Albert Ferro
Journal:  Br J Clin Pharmacol       Date:  2015-09-20       Impact factor: 4.335

Review 2.  Use of Evidence-Based Herbal Medicines for Patients with Functional Gastrointestinal Disorders: A Conceptional Framework for Risk-Benefit Assessment and Regulatory Approaches.

Authors:  Gerald Holtmann; Dietmar Schrenk; Ahmed Madisch; Hans D Allescher; Gudrun Ulrich-Merzenich; Fermin Mearin; Dominique Larrey; Peter Malfertheiner
Journal:  Dig Dis       Date:  2019-11-26       Impact factor: 2.404

Review 3.  Pharmacoepidemiology: Using randomised control trials and observational studies in clinical decision-making.

Authors:  Thomas M Caparrotta; James W Dear; Helen M Colhoun; David J Webb
Journal:  Br J Clin Pharmacol       Date:  2019-07-24       Impact factor: 4.335

Review 4.  Evolving role of pharmaceutical physicians in medical evidence and education.

Authors:  Sajita Setia; Nicola J Ryan; Prasad S Nair; Elma Ching; Kannan Subramaniam
Journal:  Adv Med Educ Pract       Date:  2018-11-02

5.  The role of in vitro testing in pharmacovigilance for ß-lactam-induced serum sickness-like reaction: A pilot study.

Authors:  Abdelbaset A Elzagallaai; Awatif M Abuzgaia; Blanca R Del Pozzo-Magaña; Eman Loubani; Michael J Rieder
Journal:  Front Pharmacol       Date:  2022-08-30       Impact factor: 5.988

6.  Hospitalizations and adverse drug events in the Brazilian unified health system: a ten-year retrospective analysis of routine data.

Authors:  Lunara Teles Silva; Ana Carolina Figueiredo Modesto; Rodrigo Alves de Oliveira; Rita Goreti Amaral; Flavio Marques Lopes
Journal:  Rev Saude Publica       Date:  2022-10-10       Impact factor: 2.772

Review 7.  Big data for bipolar disorder.

Authors:  Scott Monteith; Tasha Glenn; John Geddes; Peter C Whybrow; Michael Bauer
Journal:  Int J Bipolar Disord       Date:  2016-04-11

Review 8.  Medication safety research by observational study design.

Authors:  Kim S J Lao; Celine S L Chui; Kenneth K C Man; Wallis C Y Lau; Esther W Chan; Ian C K Wong
Journal:  Int J Clin Pharm       Date:  2016-03-22

9.  Stevens-Johnson syndrome/toxic epidermal necrolysis and erythema multiforme drug-related hospitalisations in a national administrative database.

Authors:  Bernardo Sousa-Pinto; Luís Araújo; Alberto Freitas; Osvaldo Correia; Luís Delgado
Journal:  Clin Transl Allergy       Date:  2018-01-22       Impact factor: 5.871

10.  Administration of oral fluoroquinolone and the risk of rhegmatogenous retinal detachment: A nationwide population-based study in Korea.

Authors:  Seung Yong Choi; Hyun-A Lim; Hyeon Woo Yim; Young-Hoon Park
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.